ELEVANCE HEALTH, INC. (ELV) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 201.11B USD | |
| Cost of products and services | 21.86B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $201.11B | $21.86B | (m) |
| 2026-03-31 | (m) | $200.41B | $21.66B | (m) |
| 2025-12-31 | (m) | $199.13B | $21.18B | (m) |
| 2025-09-30 | (m) | $194.82B | $21.67B | (m) |
| 2025-06-30 | (m) | $189.22B | $21.38B | (m) |
| 2025-03-31 | (m) | $183.32B | $20.91B | (m) |
| 2024-12-31 | (m) | $177.01B | $19.75B | (m) |
| 2024-09-30 | (m) | $174.22B | $18.57B | (m) |
| 2024-06-30 | (m) | $171.96B | $18.13B | (m) |
| 2024-03-31 | (m) | $171.75B | $17.64B | (m) |
| 2023-12-31 | (m) | $171.34B | $17.29B | (m) |
| 2023-09-30 | (m) | $168.62B | $16.10B | (m) |
| 2023-06-30 | (m) | $165.71B | $14.89B | (m) |
| 2023-03-31 | (m) | $160.67B | $13.63B | (m) |
| 2022-12-31 | (m) | $156.59B | $13.04B | (m) |
| 2022-09-30 | (m) | $153.25B | $12.46B | (m) |
| 2022-06-30 | (m) | $149.13B | $11.92B | (m) |
| 2022-03-31 | (m) | $144.35B | $11.46B | (m) |
| 2021-12-31 | (m) | $138.64B | $10.89B | (m) |
| 2021-09-30 | (m) | $133.88B | $10.35B | (m) |
| 2021-06-30 | (m) | $129.22B | $9.67B | (m) |
| 2021-03-31 | (m) | $124.63B | $9.28B | (m) |
| 2020-12-31 | (m) | $121.87B | $8.95B | (m) |
| 2020-09-30 | (m) | $117.45B | $7.58B | (m) |
| 2020-06-30 | (m) | $112.97B | $6.10B | (m) |
| 2020-03-31 | (m) | $109.17B | $3.98B | (m) |
| 2019-12-31 | (m) | $104.21B | $1.99B | (m) |
| 2019-09-30 | (m) | $100.18B | (m) | (m) |
| 2019-06-30 | (m) | $96.76B | (m) | (m) |
| 2019-03-31 | (m) | $94.23B | (m) | (m) |
| 2018-12-31 | (m) | $92.11B | (m) | (m) |
| 2018-09-30 | (m) | $91.41B | (m) | (m) |
| 2018-06-30 | (m) | $90.59B | (m) | (m) |
| 2018-03-31 | (m) | $90.05B | (m) | (m) |
| 2017-12-31 | (m) | $90.04B | (m) | (m) |
| 2017-09-30 | (m) | $89.07B | (m) | (m) |
| 2017-06-30 | (m) | $88.05B | (m) | (m) |
| 2017-03-31 | (m) | $87.10B | (m) | (m) |
| 2016-12-31 | (m) | $84.86B | (m) | (m) |
| 2016-09-30 | (m) | $83.34B | (m) | (m) |
| 2016-06-30 | (m) | $81.83B | (m) | (m) |
| 2016-03-31 | (m) | $80.39B | (m) | (m) |
| 2015-12-31 | (m) | $79.16B | (m) | (m) |
| 2015-09-30 | (m) | $77.95B | (m) | (m) |
| 2015-06-30 | (m) | $76.61B | (m) | (m) |
| 2015-03-31 | (m) | $75.07B | (m) | (m) |
| 2014-12-31 | (m) | $73.87B | (m) | (m) |
| 2014-09-30 | (m) | $72.79B | (m) | (m) |
| 2014-06-30 | (m) | $72.09B | (m) | (m) |
| 2014-03-31 | (m) | $71.31B | (m) | (m) |
| 2013-12-31 | (m) | $71.02B | (m) | (m) |
| 2013-09-30 | (m) | $68.99B | (m) | (m) |
| 2013-06-30 | (m) | $66.37B | (m) | (m) |
| 2013-03-31 | (m) | $63.98B | (m) | (m) |
| 2012-12-31 | (m) | $61.71B | (m) | (m) |
| 2012-09-30 | (m) | $61.49B | (m) | (m) |
| 2012-06-30 | (m) | $61.54B | (m) | (m) |
| 2012-03-31 | (m) | $61.23B | (m) | (m) |
| 2011-12-31 | (m) | $60.71B | (m) | (m) |
| 2011-09-30 | (m) | $60.12B | (m) | (m) |
| 2011-06-30 | (m) | $59.29B | (m) | (m) |
| 2011-03-31 | (m) | $58.62B | (m) | (m) |
| 2010-12-31 | (m) | $58.80B | (m) | (m) |
| 2010-09-30 | (m) | $63.20B | (m) | (m) |
| 2010-06-30 | (m) | $64.03B | (m) | (m) |
| 2010-03-31 | (m) | $64.98B | (m) | (m) |
| 2009-12-31 | (m) | $65.03B | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $61.25B | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | $61.17B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |